The Insulin Resistance Market was valued at USD 12.5 billion in 2024 and is projected to reach USD 25.0 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of diabetes and metabolic disorders, increasing awareness regarding insulin resistance, and advancements in treatment options. The demand for insulin...